Varex Imaging (VREX) Cost of Revenue (2016 - 2026)

Varex Imaging (VREX) has 11 years of Cost of Revenue data on file, last reported at $143.4 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 5.29% year-over-year to $143.4 million in Q2 2026; TTM through Apr 2026 was $569.8 million, a 3.92% increase from a year earlier, with the FY2025 full-year figure at $554.1 million, changed 0.0% from the prior year.
• Cost of Revenue for Q2 2026 stood at $143.4 million, up from $139.8 million in the prior quarter.
• Over the last five years, Cost of Revenue for VREX reached as high as $156.9 million in Q3 2022 and fell as low as $131.3 million in Q1 2025.
• Historically, Cost of Revenue has averaged $143.3 million across 5 years, with a median of $142.2 million in 2024.
• Across the five-year window, Cost of Revenue grew 10.49% in 2023 and declined 9.71% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $142.3 million in 2022, then fell by 6.61% to $132.9 million in 2023, then increased by 4.29% to $138.6 million in 2024, then rose by 9.02% to $151.1 million in 2025, then fell by 5.1% to $143.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $143.4 million in Q2 2026, $139.8 million in Q1 2026, and $151.1 million in Q4 2025.